Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Morgan Stanley Downgrades NN Group to Underweight

Morgan Stanley downgrades NN Group (OTC:NNGPF) from Equal-Weight to Underweight.

byBenzinga Newsdesk

July 21, 2021

1 minute read

Morgan Stanley downgrades NN Group (OTC:NNGPF) from Equal-Weight to Underweight.

Goldman Sachs Maintains Buy on Intellia Therapeutics, Raises Price Target to $252

By Benzinga Newsdesk

Today, 8:01 AM

Goldman Sachs maintains Intellia Therapeutics (NASDAQ:NTLA) with a Buy and raises the price target from $225 to $252.

NTLA

Deutsche Bank Maintains Buy on Union Pacific, Lowers Price Target to $260

By Benzinga Newsdesk

Today, 8:01 AM

Deutsche Bank analyst Amit Mehrotra maintains Union Pacific (NYSE:UNP) with a Buy and lowers the price target from $270 to $260.

UNP

Surgalign Holdings Q2 EPS $(1.91) Beats $(2.25) Estimate, Sales $20.62M Miss $21.13M Estimate

By Benzinga Newsdesk

Today, 8:01 AM

Surgalign Holdings (NASDAQ:SRGA) reported quarterly losses of $(1.91) per share which beat the analyst consensus estimate of $(2.25) by 15.11 percent. This is a 46.94 percent increase over losses of $(3.60) per share

SRGA

News

Infosys, Palo Alto Networks Collaborate To Secure Complex And Mission-Critical Environments For Global Enterprises

By Benzinga Newsdesk

Today, 8:01 AM

https://www.infosys.com/newsroom/press-releases/2022/secure-complex-mission-critical-environments.html

INFY

Morgan Stanley Downgrades NN Group to Underweight

Related Posts

Goldman Sachs Maintains Buy on Intellia Therapeutics, Raises Price Target to $252

Deutsche Bank Maintains Buy on Union Pacific, Lowers Price Target to $260

Surgalign Holdings Q2 EPS $(1.91) Beats $(2.25) Estimate, Sales $20.62M Miss $21.13M Estimate

Infosys, Palo Alto Networks Collaborate To Secure Complex And Mission-Critical Environments For Global Enterprises